Introduction Through Week 49, the Premium Portfolio has gained +27.75%, beating the S&P 500 benchmark, while actively trading in 14 fewer weeks according to the Momentum Gauge timing signals. These returns represent better than 3 times the return of the Barclay Hedge Fund Index average r...

The healthcare sector seems to be waking up over the past several weeks. Political uncertainty has been hurting healthcare stocks throughout the past year, but this uncertainty seems to be dissipating as the Presidential election approaches, which is being a major tailwind for the healthcare ...

Agenus ( AGEN ) is one of the most exciting biotechnology companies available at a reasonable price today. After slumping to a 52-week low of $1.95 per share back in December 2018, news of a deal with Gilead ( GILD ) to license multiple potential cancer therapies pushed the stock back up in Ja...